Kurkumin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
k dev |
k +ref |
||
Baris 8:
| accessdate = 2010-06-27
| work = Department of Medicine, UCLA; Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo
}}</ref><ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/18930076
| title = Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease
| accessdate = 2010-06-27
| work = Department of Biological and Biomedical Sciences, The Aga Khan University Medical College; Ahmed T, Gilani AH.
}}</ref><ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/19715544
| title = Optimized turmeric extracts have potent anti-amyloidogenic effects
| accessdate = 2010-06-27
| work = Center for Excellence in Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine; Shytle RD, Bickford PC, Rezai-zadeh K, Hou L, Zeng J, Tan J, Sanberg PR, Sanberg CD, Roschek B Jr, Fink RC, Alberte RS.
}}</ref><ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/19090986
| title = Immune defects in Alzheimer's disease: new medications development
| accessdate = 2010-06-27
| work = Human BioMolecular Research Institute, San Diego; Cashman JR, Ghirmai S, Abel KJ, Fiala M.
}}</ref>
| |||